LabConnect, a leading provider of central lab services and functional service provider solutions, is proud to announce the ...

In a report released yesterday, Mohit Bansal from Wells Fargo maintained a Hold rating on Merck & Company (MRK – Research Report), with a ...

BofA lowered the firm’s price target on Merck (MRK) to $112 from $118 and keeps a Buy rating on the shares. Q4 results were “decent,” but 2025 ...

Co., Inc. (NYSE:MRK), recently purchased 2,832.861 shares of the company's common stock. The acquisition, valued at approximately $249,999, was completed at a price of $88.25 per share. Following this ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

A global pharmaceutical company partnered with DelveInsight to create a robust and simplified solution enabling its top ...

Blockbuster Keytruda makes up nearly half of Merck’s sales. That’s becoming an issue.

The life sciences industry has recently been rocked by dramatic changes in how healthcare is provided, how drugs are developed and researched, the technologies available that enable companies to ...

Even for an industry that depends on relentless innovation to thrive, life sciences have seen remarkable advancements in recent decades. From the Human Genome Project paving the way for precision ...

A new era at IBD began nearly a year ago with the launch of MarketSurge, a makeover of the MarketSmith charting and research ...